Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by ...

By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in ...

Chief medical officer, Cardiosense. Previous title: Chief medical officer emeritus, Butterfly Network. Cardiosense has appointed John Martin as chief ...

The update covers devices used in procedures to implant the company’s Watchman heart device.

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for durable medical equipment ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

The U.S. alleged the company knowingly sold genetic-sequencing systems with software vulnerabilities to federal agencies.

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...